Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Galimedix Therapeutics Inc

Clinical trials sponsored by Galimedix Therapeutics Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drops aim to halt blinding disease in seniors Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 1

Can a daily pill alter brain activity in Alzheimer's disease?

Disease control Not yet recruiting

This Phase 2a trial tests an oral drug called GAL-101 in about 100 people with mild to moderate Alzheimer's disease. Participants take either 1200 mg of GAL-101 or a placebo pill once daily for 28 days, and neither they nor the study team know which they receive. The main goal is…

Phase 2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC